Baltimore, United States
Pearl Diagnostics, Inc. is carving a niche for itself in the Biotechnology and Health Care industries by focusing on the development and commercialization of diagnostic products aimed at the early detection and prevention of lung infections. Founded in 2014, the company is strategically located in the Johns Hopkins Fast Forward Accelerator in Baltimore, Maryland.
As an organization committed to innovation, Pearl Diagnostics stands out as a U.S. Small Business Administration-certified Women Owned Small Business (WOSB), which may offer investors unique opportunities for partnerships that support diversity and inclusion. The company's current lack of disclosed investment rounds may indicate opportunities for early-stage investors to engage with a growing venture poised for impact in the medical devices sector.
With its strong mission encapsulated by the slogan, "Pearl Diagnostics develops products to diagnose and prevent lung infections," this startup targets a crucial area of health care, presenting an attractive proposition for investors looking to make a positive impact in global health.
